LEADING European thermoformer TEQ:Plastique is proud to deliver a range of medical packaging solutions that are produced at state-of-the-art cleanrooms based in both the UK and Poland.
Designed, built and commissioned by pharmaceutical cleanroom experts, the facilities are certified to ISO 13485: 2016, suitable for the production of precision-made and custom thermoformed medical packaging.
The cleanrooms, located in Nottingham and Poznan, are designed to meet medical device and pharmaceutical manufacturers’ most rigorous packaging requirements.
Its packaging solutions include trays, procedure sets, clamshells, tubs, covers, lids, sterile barrier blisters and seal blisters.
The company also manufactures custom thermoformed handling trays suitable for high-speed production, with automated assembly and transit. Handling tray solutions include auto-injectors, dry powder inhalers, injection-moulded components, pre-filled syringes and pharmaceutical bottles.
The two sites are fully certified to meet the BRC IoP Global Standard which sets strict criteria for manufacturers of packaging for the food and cosmetics industries.
TEQ:Plastique’s sister company, US thermoforming business TEQ, offers facilities that enable the company to produce identical tools for packaging products previously only manufactured in the US.
“Now, with identical machinery and tooling on both sides of the Atlantic, TEQ:Plastique can offer multinational customers shortened lead times, repeatability and uniformity together with a single global validation across a range of packaging solutions for the medical and pharmaceutical industries,” says Anne-Sophie Belamine, TEQ:Plastique’s European Sales Director.
“With 40 years’ experience working with many of the world’s leading brand owners, we’re proud to be able to offer our customers a range of custom-made solutions, developed in our state-of-the-art cleanrooms in the UK, Poland and the US.
“Our facilities enable us to manufacture innovative thermoformed solutions, such as sterile barrier packaging, engineered to maximise revenue, reduce cost and increase our speed to market.”